Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. | Livzon Pharmaceutical Group Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products. | ![]() Genentech Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines. | |
Founding Date | Founding Date 1978 | Founding Date 1985 | Founding Date 1976 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations Zhuhai, CN HQ Chengdu, CN Qingyuan, CN Shanghai, CN Shaoguan, CN Shenzhen, CN Zhuhai, CN | Locations South San Francisco, US HQ Hillsboro, US Oceanside, US Vacaville, US |
Employees | Employees 7,57013% decrease | Employees 8,933 | Employees 17,823 |
Valuation ($) | Valuation ($) 26.7 b | Valuation ($) 4.2 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $9.7b (FY, 2024) | Revenue (est.) ¥12.2b (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods $2.3b (FY, 2024) | Cost of goods ¥4.5b (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit $7.4b (FY, 2024) | Gross profit ¥7.8b (FY, 2023) | Gross profit N/A |
Net income | Net income $1.6b (FY, 2024) | Net income ¥1.9b (FY, 2023) | Net income N/A |
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
View companyGenentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
View company